EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.7.1.227 | 1-phosphatidyl-1D-myo-inositol + 6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-hexanoyl)-sphingosine |
- |
Phaseolus vulgaris |
? |
- |
? |
2.7.1.227 | 1-phosphatidyl-1D-myo-inositol + 6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-hexanoyl)-sphingosine |
- |
Saccharomyces cerevisiae |
? |
- |
? |
2.7.1.227 | 1-phosphatidyl-1D-myo-inositol + 6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-hexanoyl)-sphingosine |
- |
Candida albicans |
? |
- |
? |
2.7.1.227 | 1-phosphatidyl-1D-myo-inositol + 6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-hexanoyl)-sphingosine |
- |
Candida albicans ATCC MYA-2876 |
? |
- |
? |
2.7.1.227 | 1-phosphatidyl-1D-myo-inositol + C6-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ceramide |
- |
Saccharomyces cerevisiae |
? |
- |
? |
2.7.1.227 | 1-phosphatidyl-1D-myo-inositol + hydroxy fatty acid-containing ceramide |
- |
Phaseolus vulgaris |
hydroxy fatty acid-containing inositolphosphoylceramide |
- |
? |
2.7.1.227 | 1-phosphatidyl-1D-myo-inositol + N-[(2R,4E)-1-hydroxyoctadec-4-en-2-yl]octanamide |
- |
Leishmania major |
1,2-diacyl-sn-glycerol + ? |
- |
? |
2.7.1.227 | 1-phosphatidyl-1D-myo-inositol + N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine |
- |
Candida albicans |
? |
- |
? |
2.7.1.227 | 1-phosphatidyl-1D-myo-inositol + N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine |
- |
Candida tropicalis |
? |
- |
? |
2.7.1.227 | 1-phosphatidyl-1D-myo-inositol + N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine |
- |
Aspergillus flavus |
? |
- |
? |